Clipping of news on Brazilian Culture, Law and Citizenship
07/01/2013
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Product can be used with no upper age limit; virus is the major cause of cancer of the cervix
RIO-The National Agency for Sanitary Surveillance (ANVISA) in Brazil has approved the marketing of a new vaccine against human papillomavirus (HPV), which allows to extend the age range of girls immunized. Before, only women between 10 and 25 years could take the vaccine. With the new product, Cevarix, the minimum age allowed is now 9 years old. The maximum age ceases to exist for the application of this new vaccine.
Cancer of the cervix is a major cause of death in women and the HPV virus is related to virtually 100% of cases. The National Cancer Institute estimated last year, more than 4,800 deaths from the disease.
Clinical studies with the vaccine, including Brazil, confirm 100% efficacy against HPV 16 and 18 up to 8.4 years.
Read more about this topic in
© 1996-2013. All rights reserved Infoglobo Comunicação e Participações SA This material may not be published, broadcast, rewritten or redistributed without permission.
Source: The Globe - Online
Our news are taken in full from our partner sites. For this reason, we can not change the contents of the same even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.